ORBIMED ADVISORS LLC: MLYS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on MLYS, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 2,110,300 MLYS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 2,110,300 sharesChange vs previous 13F +57,400 shares
1.08% of the 13F portfolio, value $56,935,894.
13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,052,900 sharesChange vs previous 13F +1,072,500 shares
1.21% of the 13F portfolio, value $55,613,061.
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 980,400 sharesChange vs previous 13F -489,094 shares
0.73% of the 13F portfolio, value $35,578,716.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,469,494 sharesChange vs previous 13F +709,143 shares
1.34% of the 13F portfolio, value $55,723,212.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 760,351 sharesChange vs previous 13F +760,351 shares
0.26% of the 13F portfolio, value $10,287,549.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -1,611,637 shares
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 1,611,637 sharesChange vs previous 13F -391,302 shares
0.41% of the 13F portfolio, value $19,839,251.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 2,002,939 sharesChange vs previous 13F not available
0.44% of the 13F portfolio, value $24,255,591.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).